The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered ...
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
The maximum human lifespan hasn't moved past 115 years. But is that about to change?
Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
The V.I. Public Finance Authority board on Thursday approved a $1.5 million payment to the V.I. Port Authority, following ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...
Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.